M
MEDADOM
Medical teleconsultation player in France which provides patients with medical practitioners for a digital and unscheduled access to care through video-consultations
About MEDADOM
Medadom is a telemedicine platform that facilitates remote consultations with healthcare professionals, providing an accessible and convenient solution for patients seeking medical advice. The company operates in the digital healthcare market, targeting individuals who require medical consultations but prefer or need to avoid in-person visits. Medadom's business model revolves around offering teleconsultation services through its platform, where patients can connect with doctors and other healthcare providers via video calls. The company generates revenue by charging fees for each teleconsultation session conducted through its platform.
Medadom's primary clients include individuals seeking medical consultations, healthcare professionals looking to offer remote services, and potentially healthcare institutions aiming to integrate telemedicine into their service offerings. The platform's user-friendly interface and comprehensive service make it an attractive option for both patients and healthcare providers.
In summary, Medadom leverages technology to bridge the gap between patients and healthcare professionals, ensuring that medical advice is accessible from the comfort of one's home. The company's focus on telemedicine positions it well within the growing digital healthcare market.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2016
- Headquarters
- Paris, France
- Employees
- 227
- Open positions
- 7
- Dealroom signal
- 87.1/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Critical medical care, Telemedicine, Hard Tech, Digital Care, observatoire healthtech, FrenchTech120
- Technology
- Mobile app
- Business model
- Marketplace & ecommerce, SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| BUYOUT✓Exit | May 2026 | $0 | — | Verdane Capital | ↗ |
| LATE VC✓Equity / VC | Mar 2026 | $0 | — | Verdane Capital · Bpifrance | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for MEDADOM is 860K monthly website visits, up 6.2% over the last three months. MEDADOM's team grew 18.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
G Square
Series B and later2 investors entered at this stage
Verdane Capital
Bpifrance
Other known investors4 additional known investors
HEC Paris
HEC Paris Incubator
Bernard Kalfon
YADAY
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MEDADOM on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MEDADOM’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.